Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · IEX Real-Time Price · USD
1.760
-0.120 (-6.38%)
Jul 17, 2024, 4:30 PM EDT - Market closed

Lyell Immunopharma Market Cap

Lyell Immunopharma has a market cap or net worth of $448.69 million as of July 17, 2024. Its market cap has decreased by -43.48% in one year.

Market Cap
448.69M
Enterprise Value
-18.91M
1-Year Change
-43.48%
Ranking
Category
Stock Price
$1.76

Market Cap Chart

Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $448.69M, a decrease of -89.13%. That is a compound annual growth rate of -51.33%.

History

DateMarket Cap% Change
Jul 16, 2024479.30M-1.90%
Dec 29, 2023488.60M-43.53%
Dec 30, 2022865.20M-53.51%
Dec 31, 20211.86B-54.91%
View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Editas Medicine 490.14M
Oculis Holding AG 488.93M
Theravance Biopharma 485.85M
Korro Bio 485.44M
Enhabit 484.01M
Kyverna Therapeutics 477.29M
Precigen 474.55M
Eliem Therapeutics 471.50M
Market Cap Rankings